IE902467A1 - Immobilised polynucleotides - Google Patents

Abstract

Nucleotides can be linked from a 5'-phosphate residue to a support via a dithio (-S-S-) linkage. Polynucleotides thus immobilised can be used in the polymerase chain reaction (PCR) at which a temperature of 90 DEG C is typically required. The -S-S- linkage can be produced by reaction of a thiolated support with a 5'-(thiol-terminated) polynucleotide. For ease of hybridisation of the immobilised polynucleotide, the sequence to be hybridised should be adequately spaced from the support. The invention is useful in any situation in which a polynucleotide such as DNA is required to be separated as a solid phase from a liquid phase, especially in heterogeneous assays and to isolate products of the PCR.

Description

1. Field of the Invention This invention is in the field of assays for polynucleotides, principally DNA, and relates to the immobilisation of polynucleotides on a support material. 2, Description of the prior art The polymerase chain reaction (PCR), see U.S. Patent 4,683,202 (Mullis), R.K. Saiki £l aL, Science 230. 130-154 (1985) and H.A. Erlich a1, Nature 331, 461-462 (1988), allows a nucleic acid sequence to be amplified. As applied to DNA, the process comprises the steps of denaturing a duplex to produce two single-stranded (ss) molecules, synthesising complementary DNA to each ss DNA by oligonucleotide priming synthesis, thereby producing a duplex from each ss DNA molecule, denaturing the duplex to produce two ss DNA molecules (one of the original length, one of length governed by the position at which priming began), using each of these molecules as the template for a further primed synthesis and so on for as many cycles as desired. In view of the use of heat to denature the DNA, the DNA polymerase enzyme used for the primed synthesis 1s preferably one which 1s stable at the denaturing temperature, in order to avoid addition of fresh polymerase at each cycle. The use of a heat-stable polymerase from Thermus aauaticus enables the PCR amplification of DNA (directly from DNA, or indirectly from RNA) to be carried out at temperatures ranging from 30 to 100’C, at various stages of the process and dependent on the nature of the sequence to be amplified, in automated equipment.

The PCR is potentially of immense value in diagnostics since it enables either the analyte nucleic acid or the duplex produced upon hybridisation of the analyte to a labelled probe to be amplified and thereby very small amounts of nucleic acid to be detected. An amplification of 102θ within 4-6 hours is possible. - 2 Hybridisation of native and/or synthetic DNA to complementary DNA/RNA sequences 1s critical to the performance of PCR and many other DNA/RNA assays. Detection of analyte sequences with or without amplification 1s also dependent on hybridisation of complementary sequences to a labelled probe. Most of these present techniques require Immobilisation of the analyte or probe sequences (e.g. to nylon membranes) prior to hybridisation. Consequently the time and complexity of the protocols Increases whilst non-specific linkage employed reduces the amount of specific analyte or probe available for hybridisation.

Separation and concentration of amplified analyte sequences by solution hybridisation following PCR 1s highly desirable to readily enable detection and Increase sensitivity (and quantitation) and decrease Incubation times by favouring the kinetics.

The linkage of oligonucleotides to solid phase particles for collection, separation and detection of analyte sequences by solution hybridisation has been Investigated by several groups [see review by J.A. Matthews and L.J. Krlcka, Anal. Biochem. 169. 1-25 (1988)]. Matrices commonly used have been control pore glass [S.S. Ghosh and G.F. Musso, Nucleic Acid Res. 15, 5353-5390 (1987)1, latex [S.F. Wolf fit al., Nucleic Acid Res. 15, 2911-2926 (1987)], polystyrene [Y. Nagata at al., FEBS Lett. 153, 379-382 (1985)], cellulose [T. Goldkorn and D.J. Prockop, Nucleic Acids Res. 14, 9171-9191 (1986)] and magnetically attractable beads of cellulose [J.A. Langdale and A.D.B. Malcolm, Biochem. Soc. Trans. 12, 693-694 (1984) and P.J. Nicholls, J.A. Langdale and A.D.B. Malcolm, Biochem. Soc. Trans. 15, 140 (1987)] or styrene polymer [V. Lund £i al·, Nucleic Acids Res. 15, 10861-10880 (1988)].

Several chemistries have been applied to the attachment of the oligonucleotides, based on linkage via carboxy or amino groups (e.g. using carbodiimide or cyanogen bromide or tosyl-activated beads) [J.A. Langdale and A.D.B. Malcolm, Biochem. Soc. Trans. 12, 693-694 (1984), R. Polsky-Cynkin ai al-.Clin. Chem. 21, 1438-1443 (1985), J.A. Langdale and A.D.B. Malcolm, Gene - 3 201-210 (1985), V. Lund el el., Nucleic Acids Res. If, 10861-10880 (1988), P.J. Nicholls, J.A. Langdale and A.D.B.

Malcolm, Biochem. Soc. Trans. 15, 140 (1987), L. Clerlcl el el·, Nucleic Acid Res. f, 247-257 (1979), D. Rlckwood Biochem.

Blophys. Acta 240, 515-521 (1973), H. Bunemann, P. Westhof and R.G. Herrmann, Nucleic Acid Res. 10, 7163-7181 (1982) and A. Jungel1-Nortamo el el·, Molecular and Cellular Probes 2, 281-288 (1988)] or Introduction of electrophilic groups at the 5' end of the ollgo and then reacting the ollgo with a nucleophilic residue on the support [J.N. Kremsky et el·, Nucleic Acid Res. 15, 2891-2909 (1987)]. Specific attachment of oligonucleotides has been achieved to varying degrees by all methods (generally of 10-20 pg or 0.04-1.0 nM oligonucleotide per mg of beads). However, the availability of amino and carboxyl groups on the nucleotide side arms resulted 1n poor specific coupling via the 5' end of the oligonucleotide. Consequently, only a small proportion of the attached oligonucleotide 1s available for hybridisation (typically femtomole amounts of analyte per mg of beads) [S.S. Ghosh and G.F. Musso, Nucleic Acid Res. If, 5353-5390 (1987)].

In the Goldkorn and Prockop paper, ol1go-dT cellulose is linked to an oligonucleotide via a polynucleotide chain by the steps of (1) poly dA—tailing the 3'-ends of a double-stranded oligo, (2) hybridising the poly dA-tailed DNA to the oligo-dT cellulose, (3) filling 1n the gap between the last dT of the ol1go-dT cellulose and the 5'-end nucleotide complementary to the 3'-nucleot1de onto which the poly A tail was added, by the T4 11gase/Klenow fragment method and (4) separating by heat denaturatlon the f1lled-1n strand, now attached to the ollgo dT cellulose, from the other strand, which 1s attached to the ollgo-dT cellulose only Indirectly, via Its complementary strand, as a result of the dA-dT hybridisation. This procedure Involves multiple steps and expensive reagents and 1s exclusive to cellulose, this being the only known support to which a dT chain can readily be linked. - 4 Various other esoteric linkages are mentioned in the Matthews and Kricka review paper, see Table 7 on page 15.

A-C. Syvanen, Nucleic Acids Research 16, 11327-11338 (1988) describe 5’-b1ot1ny1 at1 ng DNA molecules and joining them to avidin-coated polystyrene particles. The particles are used to capture 51-biotiny1ated products of the PCR. This methodology cannot be used in the PCR Itself because the biotin/avidin interaction is not sufficiently heat-stable.

Summary of the invention It has now been found that nucleotides can be linked to a support via a dithlo (-S-S-) linkage, which results in exceptional stability of linkage. In particular, the supported polynucleotide can participate in a PCR reaction carried out at elevated temperature. The dithlo linkage is formed by coupling a thiol (-SH) group or a reactive derivative thereof on the polynucleotide with a thiol group or reactive derivative thereof on the support. Further, when a polynucleotide is thus linked, then, provided that the support is sufficiently distanced from the sequence of Interest, that sequence can be hybridised strongly to a labelled complementary probe.

Since the dithlo linkage Is stable at the highest temperature (about 90°C) typically used In the polymerase chain reaction (PCR), polynucleotides thus linked to beads can be used in the PCR. They are also useful for a variety of purposes in heterogeneous assays of nucleic acids.

Accordingly, an important feature of the Invention consists in an Immobilised polynucleotide material comprising a support bound to a 5'-end of at least one polynucleotide through a linkage which Includes a dithlo (-S-S-) group. The term polynucleotide encompasses DNA, RNA, oligonucleotides and any modified or labelled form of conventional nucleic acid In which pairable bases are arranged in helical chains.

An Important subsidiary feature comprises an Immobilised polynucleotide material comprising a support bound to a 5'-end of - 5 at least one polynucleotide which contains a c-target base sequence complementary to a target base sequence of Interest, said support being bound through a linkage as defined above and which 1s effective to distance or space the support from the c-target sequence so as to permit the c-target sequence to hybridise to the target sequence. (References herein to hybridisation are to be construed to include annealing of primers to longer sequences as occurs In the PCR).

It has been found that the linkage In this Invention results in a particularly high degree of hybridisation, probably because, unlike the CNBr and carbodiimide methods of attachment normally used, 1t Is specific to 5'-end attachment. It 1s believed that In these conventional methods, there 1s some reaction between amino groups on DNA bases and the activated supports. The resultant attachment of supports to mid-chain bases would interfere with base-pairing and therefore hybridisation.

The Invention further provides a method of carrying out a polymerase chain reaction (PCR) in which an Immobilised polynucleotide material of the Invention Is substituted for either or both of the oligonucleotide primers used In the PCR and the amplified product of the PCR Is separated on the solid phase. Thus, as applied to a conventional PCR, the c-target sequences of two immobilised polynucleotides anneal to respective target sequences of the polynucleotide to be amplified, one 25 target sequence being at a 5'-end of one strand and the other being , at the 5'-end of the other strand. In another aspect, the Invention Includes a method of heterogeneous assay for an analyte nucleic acid, which comprises subjecting the Immobilised polynucleotide material of the Invention, having a c-target sequence, to hybridisation with the target sequence of analyte nucleic acid present 1n a liquid phase analyte, separating the phases and determining the occurrence or extent of hybridisation. Preferably, the analyte nucleic acid Is labelled either directly or by hybridisation at a second site thereof with a labelled complementary polynucleotide. Such an assay is preferably used 1n conjunction with a liquid phase PCR, to detect a product of the PCR. It can also be used 1n any nucleic acid assay context.

The Invention further includes a method of producing an immobilised polynucleotide material of the invention which comprises reacting a S'-Cthlol-terminated) derivative of a polynucleotide with a support having a thiol group thereon, either or both of said thiol groups being optionally derivatised as co-react1ve -S-S- linkage-producing derivatives, to form a said -S-S- linkage between said thiol groups. Any chain atoms (a) between support and its pendant thiol group and (b) between 5'- nucleotide phosphate residue and its pendant thiol group are preferably thermally stable at the maximum temperature likely to be essential 1n the PCR reaction, normally 90°C-100°C.

For most, but not necessarily all, uses of the invention, the support needs to be distanced from the sequences which it is desired to hybridise. Desirably, the spacing is provided wholly by the linkage, that is to say between the 5'-end of the last nucleotide and the support. However, it could be provided partly or wholly by attaching a sequence of irrelevant nucleotides to the last nucleotide of Interest and providing the thiol termination on the last of the irrelevant nucleotides. In other words, the spacing between the last nucleotide of Interest, usually a c-target nucleotide, and the support can contain nucleotides.

Additional description of prior art Oligonucleotides having a thiol (SH) group pendant from the 5'-terminus are not, as a class, novel. B.A. Connolly and P. Rider, Nucleic Acids Research JJ, 4485-4502 (1985) prepared such compounds by reacting S-trityl-w-mercaptoalkanols with 0-methoxymorphol1 nochlorophosphate to give S-tr1tyl-0-methoxymorphol1 nophosphites of formula och3 Ph3-S-(CH2>X-O-P I where Ph = phenyl and x = 2, 3 or 6, and then coupling these compounds with oligonucleotides which had been prepared by a solid phase phosphoramidite method, oxidising the resultant phosphite to phosphate, and de-protecting the thiol group. Connolly and Rider used these compounds in reactions to label the thiol-terminated oligonucleotides with the fluorophore, N-iodoacetyl- N'-(5-sulpho-l-naphthyl)ethylenediam1ne (AEDANS) or N-(l-anilino-4-naphthyl)male1imide (ANM). In the reaction with AEDANS, the iodine atom is displaced, forming a -S-CH^-COlinkage, while in the reaction with ANM an electrophilic addition of the double bond produces a linkage: In PCT Patent Specification W0 89/02931 (Cetus) published 6th April 1989, oligonucleotide functionalizing reagents are described. These have a pendant thiol, amino or hydroxyl group linked to the 5'- phosphate group by a spacer chain of formula -(CH2>2-H2CH2}n“CH2CHR*-O- where the oxygen atom shown is that of the phosphate group and R* represents H, CH2OH or trltylated CH20H. These reagents are used for reaction with a horseradish peroxidase (HRP) derivative 1n order to label the oligonucleotide with an enzyme. The HRP derivative has a malellmide termination, producing the same kind of linkage as described In the Connolly and Rider paper.

Thiol linkages have been used to attach proteins to supports. See, for example, Solid Phase Biochemistry ed. W.H. Scanten, John Wiley & Sons 1983, Chapter 7 Immobilized Enzymes by John F. Kennedy and J.M.S. Cabral, pages 301 and 302 Affinity Chromatography - principles and methods, published by Pharmacia AB, 1986-1988, pages 35-45. - 8 Brief description of the drawings Figs. 1 and 2 are graphs in which the amount of hybridisation achieved by immobilised polynucleotides of the invention, assayed by heat-denaturing labelled hybrids, is represented by plots of amounts of labelled material released from the hybrids into solution against temperature of denaturation and compared with various controls; Figures 3 and 4 are similar graphs but referring to immobilised polynucleotides of the prior art; and Figure 5 is a similar graph showing the effect of the inclusion of a spacer arm In the immobilised polynucleotides of the invention.

Description of the preferred embodiments While the preferred use of the invention, as currently 15 contemplated, is in the PCR reaction, the invention can be used in the context of any procedure of immobilising or insolubi1ising a polynucleotide, especially a heterogenous assay procedure. Thus, the invention is applicable in such assay procedures described in the above-mentioned Matthews and Kricka review paper. 20 The support material is not critical and can be any of those conventionally used. One convenient material is beads which already have thiol groups attached. These are available commercially for the purposes of affinity chromatography of proteins. See, for example, the above-cited Affinity 25 Chromatography - principles and methods, published by Pharmacia AB, which describes S-protected thiolated Sepharose beads of formula: Sepharose residue -O-CH2-CH(OH)-CH2-S-S(the 2-pyridyl group being protective).

Various glasses can be used as supports when activated to provide suitable functional groups. Thus controlled pore glass (CPG) or any other glass of high surface area can be used.

Virtually any conventional chemical linkages can be used in building up a chain between the support to the -SH termination, 35 even the CNBr or carbodi imide method, so long as they do not - 9 provide the final attachment to the polynucleotide. Obviously, for use in the PCR, thermally susceptible linkages are to be avoided.

While the elements of the linkage can be provided In any order, 1t will be appreciated that it is desirable not to cause any reaction which might be non-specific. It will almost always be desirable to form the -S-S- bond last when preparing the immobilised polynucleotides. By way of example a conventional aminoalkylating agent can be reacted with a support such as CPG to provide amino terminations. The amino-functional support can then be reacted with cysteine in a peptide coupling reaction to provide the SH termination required. However, preliminary indications suggest that such a cysteine link might not produce the desired high specificity of binding of the support to the DNA to be Immobilised and at present a mercaptoalkyl termination is preferred. Thus, a support, such as CPG is preferably silanised by an (ω-mercaptoalkyl) trlmethoxysilane, conveniently (3-mercaptopropyl) trimethoxysilane. This silanised support is then reacted with the thiol- terminated polynucleotide.

The linkage between the polynucleotide and the support will normally include a spacer arm between the polynucleotide and the -S-S- linkage, the -S-S- linkage and the support, or both. Alternatively or additionally the polynucleotide can itself contain a spacer arm, of one or more nucleotides, usually 3 to 20 and preferably 4 to 15, between Its 5'-end and the nearest relevant nucleotide. Where the polynucleotide is a sequence complementary to another sequence to which It is to be hybridised, the relevant nucleotide will be the last nucleotide of that complementary sequence, (the c-target sequence). This nucleotide spacer arm consists of Irrelevant polynucleotides which do not interfere with or participate in hybridisation. For the purposes of reckoning its length, the nearest relevant nucleotide is not counted in, but the 5'-end nucleotide is counted in. The total length of spacer arm (whether in the linkage or the polynucleotide or both) will depend on the nature - 10 of the linkage and its spatial configuration. In general, a straight chain of from 5 to 27 atoms and nucleotides between the support and the relevant 5'-end nucleotide (inclusive of the two S atoms) Is suggested. Too short a chain would tend to bring the support too close to the polynucleotide chain for successful hybridisation to occur, while if the linkage Is too lengthy the support might dangle at such a distance as to wrap itself over the relevant 5' end nucleotide and its neighbours. This would probably Interfere with successful use of a supported oligonucleotide as a primer in the PCR.

Preferably the total spacer arms conform to the general formula (N)x-(Lj)y-S-S-(L2)2 e.g. in the manner illustrated below, using arbitrary, imaginary sequences: —NNNGCTTAGCTNNNNNNNNNNN 3' CGAATCGA 5’ \ (N)x-(L-j )y-S-S-(l-2>z-Support where the top sequence is that of the target (analyte) polynucleotide, the bottom sequence is that of an oligo primer immobilised according to the invention; N represents a nucleotide in the spacer arm upstream of the end of the c-target sequence; L] and L2 represent atoms 1n a covalent chain from the end nucleotide to the support, on each side of the two sulphur atoms of the -S-S-linkage; x, y and z are 0 or Integers and the sum of x, y and z is 3 to 25, preferably 4 to 25, especially 6 to 20.

It will be appreciated that the Invention is usable merely for isolating a polynucleotide without necessarily hybridising or annealing 1t. In such circumstances a spacer arm will frequently offer no advantage.

The PCR is described in the above-cited references, the disclosures of which are herein incorporated by reference. Any nucleic sequence can be specifically amplified by the PCR. It 1s only necessary that a sufficient number of bases at each end be - Il sequenced so that two oligonucleotide (ollgo) primers can be prepared, complementary to sequences at or near the ends of each strand or, at least, sufficiently well separated that the sequence of Interest lies between the 3'-ends of the two primers. One ollgo primer 1s called the forward primer, because 1t primes 5' to 3' synthesis of complement to the coding strand of the polynucleotide. The other 1s the reverse primer which primes 5' to 3' synthesis of complement to the non-coding strand. If neither strand codes, the designations are arbitrary.

The PCR normally comprises broadly three steps per cycle: (1) annealing forward and reverse oligonucleotide primers to the strands of a polynucleotide to be amplified, these strands having been first separated, annealing being carried out typically at a temperature of 30 to 60°C; (2) extending the primed sequences along their respective template strands of the polynucleotide to be amplified, at a temperature typically of 60 to 80eC. (3) separating the synthesised strands from their templates at a temperature effective for this purpose, typically from 80 to 100°C, especially at about 90°C.

The cycle Is then repeated, using the products of each separation step (3) as the templates for the ensuing annealing step (1) of the next cycle. Products are conveniently detected by labelling the nucleotides used for the chain extension and determining the label attached to the products. Labelling can be done radloactlvely e.g. with 32P or by biotinylation, for example, and the labelled products Immobilised and separated from the reaction medium. In another mode, the PCR can be carried out 1n solution and the products detected by carrying the PCR to the end of a separation step <3>, and probing the strands with a probe which Is attached to a support or to which a support Is later attached. The amount of label attached to the support 1s then determined.

Of course, 1t 1s not critical to label the nucleotides Incorporated 1n the PCR. Instead the PCR products can be - 12 subjected to a sandwich assay In which a two-site probe Is used, site A being capable of binding specifically to the PCR product which It 1s hoped to detect and site B being capable of hybridising with an Immobilised polynucleotide of the Invention.

Another method of detecting PCR products on a solid support depends on measuring the thickness of the layer deposited on the solid phase. This can be done by measuring changes of optical path through the layered film: see literature of Medical Products Inc., Boulder, Colorado, USA.

It 1s also possible to use the 5' thlol-derlvatlsed primers (carrying a free or protected -SH group) In solution In the PCR and subsequently linking the amplified labelled (or unlabelled) products to the thiol-derlvat!sed solid support by means of the invention. The attached PCR products may be detected by any number of methods Including those cited above.

Products attached to the solid phase through the linkage of the invention can be released therefrom by any of the known methods of breaking -S-S- bonds, such as by prolonged action of a high concentration of dlthlothreltol or 2-mercaptoethanol. Note, however, that the relatively low concentrations of these reagents often present 1n conventional PCR buffer systems will not normally break the S-S bonds.

Any number of polynucleotides can be linked to the same Integral unit (particle, sheet, bead, tube etc.) of the support material, provided that there Is no Interference between polynucleotides which would hinder their end use, e.g. 1n an assay.

The following Examples Illustrate the Invention.

EXAMPLE 1 Example 1 Illustrates the hybridisation capacity of an oligonucleotide bonded to a support via an -S-S- linkage, 1n accordance with the Invention. The oligonucleotide was used with and without a 4-nucleotlde spacer between the c-target sequence and the 5'-end.

All operations were carried out at room temperature (about °C) except as otherwise described. - 13 THE OLIGONUCLEOTIDES AND PROBES USED The oligonucleotide synthesised for coupling to the beads 1s that of the forward primer complementary to a sequence of the human papilloma virus type 16 successfully applied In the PCR for amplification of a 120 base-pair fragment of HPV16 DNA: ' TCAAAAGCCACTGTGTCCTG 3' (20mer) D99 (in-house designation) Identified as Sequence ID No. 1. (1) To prepare a thiol-terminated ollgo, a 5'-spacer was added, composed of an additional 4 dTTP residues, the last 5' terminal dTTP being a fully protected thiol phosphoamldlte. (2) For comparative purposes, the same ollgo as In (1) above was prepared, except that an aminolink II was Incorporated on the terminal 5' dTTP (4 dTTP spacer Included). Aminolink II is a reagent sold by Applied Biosystems Inc. for derlvat1sation of the '- terminus of a synthetic oligonucleotide. It 1s a methyl phosphoramidite of formula CF3CO NH(CH2)6OP(OCH3)N[CH(CH3)2]2 and Is used In the beta-cyanoethyl phosphoamldlte synthesis to Introduce an aminohexyl termination (the terminal CF3CO- group being cleaved off at the end of the synthesis). (3) The hybridisation probes prepared were either a sequence complementary to 099 I.e: 3' AGTTTTCGGTGACACAGGAC 5’ (ant1-D99) Identified as Sequence ID No. 2. or, as a control, the reverse primer sequence ollgo for HPV16 I.e: 3' ACGTCTAGTAGTTCTTGTGC 5' (non-complementary to D99 ollgo) Identified as Sequence ID No. 3.

SYNTHESIS OF OLIGONUCLEOTIDES The ollgos were synthesised on a Biotech Instruments BT8500 automatic machine, using the well established cyanoethyl phosphoamldlte coupling chemistry. The last base to be added at the 5' end of the ollgo was a fully dlmethoxytrltyl protected, thiol phosphoamldlte, Introduced via line Q on the BT8500. The ollgo was cleaved from the controlled pore glass solid phase 1n the normal way with aqueous ammonia, using a 'trityl ON1 cleavage method. The free oligo was then dried at 50°C under vacuum. It Is stable for long periods at -20°C. - 14 COUPLING OF THIOL-TERMINATED OLIGONUCLEOTIDE TO BEADS VIA DITHIO LINKAGES. (1) activation of thiol ollgo: 0.04 μ/nole of the ollgo, (10 0D2gQ units) was dissolved in 100 μΐ of 0.1M triethanolamine acetate (TEAA) buffer pH 7.5. 15μ1 of 1M silver nitrate solution was added, vortexed, and incubated at room temperature for 30 mins. This cleaved the dimethoxytrityl protective group off the thiol, with approx. 707. efficiency. 20μ1 of 1.0M d1thlothre1tol (DTT) was added, vortexed and reacted for 5 mins. The reaction mixture was centrifuged at 3000 rpm for 5 mins and the supernatant removed. ΙΟΟμΙ of TEAA buffer was added to the precipitate, which was vortexed, centrifuged and the supernatants combined. This oligo solution was stable for months at -20°C. (ii) Activation of beads and coupling: Either 0.04 or 0.4 pmole of Biomag 4135 thiol-terminated magnetic affinity chromatography support beads, a product of Advanced Magnetics Inc., Cambridge, Mass. USA, available in the UK from Metachem Diagnostics Ltd. of Northampton, (either lmg, 60μ1 or 10 mg, 0.6 ml.) were washed 3 times with 0.05M TEAA buffer to remove all mercaptoethanol. The above-prepared ollgo solution (200μ1) was added, and vortexed. The solution was extracted 3 times with ethyl acetate and twice with diethyl ether to remove all DTT and nitrogen was blown over solution to remove all the solvent. 40 μΐ of iodine solution (lOOmg per ml in glacial acetic acid) was added. The supernatant (minus beads) should be brown at this stage; if not, Iodine solution should be added 1n 20μ1 aliquots until It turns brown. The solution and beads were then vortexed and reacted for 30 min. to couple the beads to the oligo. After coupling, the beads were centrifuged and washed three times with 0.05M TEAA buffer to remove iodine and were then ready for use. To date, 70% of the activated ollgo has been shown to bind to the beads, I.e. a total of 0.02 pmoles per lmg or 10 mg of beads. Since the protective group Is cleaved with 70% yield and 70% of the activated oligo binds to the beads, - 15 the yield 1s 70% -= 49% with respect to the original ollgo.

COUPLING OF AMINE-TERMINATED OLIGONUCLEOTIDE TO BEADS (a) via cyanogen bromide.

The amino-terminated D99 (4dTTP spaced) ollgo (2) prepared above was coupled to Dynabead M450 beads (Dynal UK Ltd) having -OH active groups according to the method described by V. Lund et. al.. loc. £_L±- (0.04μ mole DNA to 10 mg of beads).

Beads were activated by Incubation for 30 mins. In distilled water, followed by raising the pH to 11.5 with 2M sodium hydroxide and Incubation for 50 mins. 30mg of cyanogen bromide was added and the pH re-adjusted to 11.5 with 2M sodium hydroxide. The beads were Incubated on a roller for 10 mins followed by 5 washes with distilled water and resuspended In lOmM sodium bicarbonate buffer, pH 8.4 0.08 pmole of ollgo was added to 1ml of 1-methyl Imidazole buffer pH 7 (Sigma) containing 0.1M l-ethyl-3-(3-d1methylaminopropyl) carbodiImide (S1gma>, 0.25M ethylenedlamlne (Sigma) and incubated at 50°C for 3 hrs. 60 μΐ of 3M sodium acetate, pH6.5 were added and 1 ml Ice cold ethanol, mixed and Incubated at -80°C for 2 hrs. The precipitate (comprising the amineactivated ollgo), after centrifugation, was dried In a vacuum desslcator and reconstituted 1n 600 μΐ 10 mM sodium bicarbonate buffer, pH8.0.

The above 600 μΐ (0.08 pmole) of activated ollgo was mixed with 10 mg amine activated beads and Incubated for more than 24 hrs on a roller. Control couplings were also performed using unactivated beads Incubated with activated ollgo or activated beads with unactivated ollgo. (b) via carbodiImide Ollgo was coupled to M450 beads via carbodiimide according to the above Lund £± £L· reference. Thus, 0.08 pmole of activated ollgo was added to 10 mg beads 1n the presence 0.04M sodium 2-(N-morphol1no)ethane sulfonate containing 25 mg l-cyclohexyl-3(2-morpholInoethyl)carbod1Imide and Incubated overnight at 45’C.

Control couplings were performed 1n the absence of the - 16 carbodiimide reagent.

PREPRARATION OF PROBES Anti-099 oligo was 3' end labelled with 32P-d1deoxyATP using a kit supplied by Amersham International pic and separated on a G-50 Sepharose column. Labelled ant1-D99 was added to unlabelled ant1-D99 to give a 4-5% label concentration. HYBRIDISATION OF THE IMMOBILISED OLIGONUCLEOTIDES TO LABELLED PROBES Beads with or without oligo (0.02 pmole per mg. or lOmg) attached by the methods described above were incubated with a molar excess (0.03 pmole) of antl-D99 (per mg. or 10 mg of beads) (4-5% 3'-end labelled with 32P) in 2 x saline sodium citrate (SSC) buffer at 40°C for 2.5 hrs (1ml total volume). The supernatants were removed and discarded and the beads washed 4 times in 2 x SSC at 40°C, to remove thoroughly excess labelled probe.

MEASUREMENT OF AMOUNT OF HYBRIDISATION The hybridisation capacity of the oligos attached to the beads was then measured by dissociating the labelled probe DNA strand from the bead-bonded oligo strand and measuring the amount of label released Into solution. Thus, the beads were then sequentially incubated in 0.5ml of 2 x SSC for 5 mins at 10°C temperature increments up to 90*C, supernatants were removed at the end of each cycle and the number of radioactivity counts per minute (cpm) assessed by Cerenkov-counting. A final further incubation of 90eC in the presence of 2% mercaptoethanol in 2 x SSC was performed and the cpm in the supernatant and remaining on the beads determined.

The results are shown graphically in Figures 1-4 of the drawings in which temperature is plotted on the abscissa and radioactivity released into solution in cpm on the ordinate. At the right-hand side, on a separate abscissa and ordinate the radioactivity remaining on the beads after the final 90eC wash is shown.

Figure 1 relates to 10 mg beads dlthio-coupled to 0.2 pmole - 17 of oligo D99. The filled squares show the cpm values obtained using the dithio-coupled beads hybridised to labelled complementary oligonucleotide, while the open triangles show the cpm values for the same beads Incubated under the hybridisation conditions with the control non-complementary oligonucleotide. The open circles depict the amount of label 1n the supernatant using unactivated thiol beads (1.e. 1n the absence of D99) Incubated under hybridisation conditions with the complementary (antl-D99) or non-complementary probes (the results were the same whichever probes were used). The right hand side shows the cpm remaining on the beads after the 90°C wash In the presence. 2-mercaptoethanol breaks the -S-S- bond, so these results are a measure of non-specific binding. Similar results (not shown) were obtained 1n the absence of mercaptoethanol (mean of two experiments).

It will be seen that a satisfactory curve was obtained with the hybrids formed from the d1thlο—11nked beads of the invention. As expected, dissociation of the hybrid strands Increased with elevated temperature. The curve 1s Indicative of strong hybridisation.

Figure 2 shows the results obtained from the same experiments performed using 10 mg of beads with or without 0.2 pmole of ollgo D99 coupled via the dlthlo linkage. Filled squares show cpm 1n supernatants from dlthio—1 inked D99 beads hybridised to labelled complementary (ant1-D99), probe whilst open circles represent values obtained using unactivated beads with labelled ant1-D99. The results for unactlvated beads Incubated with non-complementary ollgo, and d1th1o-1inked D99 beads Incubated with non-complementary ollgo are omitted for clarity because they were almost Identical to the open circle results, with one exception. The exception was that the dith1o-l1nked D99/non-complementary ollgo gave a radioactivity count on the beads between that for d1th1o-lInked D99/non-complementary ollgo (filled square) and the unactlvated/complementary ollgo (open circle). - 18 The results for the dithio-1inked beads of the Invention were more erratic than in Figure 1, doubtless due to the low ratio of oligo to beads in the coupling reaction.

STABILITY OF LINKAGE It has also been determined that the dithio-1Inked D99 oligo, either without any nucleotide spacing or with the 4dT spacing as above (0.2pm per lOmg of the above-described beads) withstands pre-1ncubat1on for 5 to 30 minutes at temperatures of 60 to 90eC before hybridisation. After carrying out hybridisation and measurement of the amount of hybridisation, as described above, the number of radioactivity counts obtained was satisfactorily high, the maximum being about the same order as that of Figure 1. COMPARATIVE EXPERIMENTS Figure 3 shows the results of Identical experiments obtained with 10 mg beads coupled to 0.08 micromole of D99 via the cyanogen bromide linkage. Filled circles show cpm in supernatants after hybridisation with an excess of tracer anti-D99 whilst the open symbols show the values obtained using unactivated beads hybridised to labelled ant1-D99 or incubated with non-complementary oligo, or coupled beads Incubated with labelled non-complementary oligo.

The results in Figures 3 and 4 ought to be multiplied by 2.5 in order to be comparable with Figure 1 (because of the different ratio of beads to oligo 1n the coupling reaction). However, this would not significantly affect the comparison because the degree of hybridisation of the dithio-1inked ollgos of the Invention is of the order of 100-fold greater (10$ cpm versus 103 cpm).

Figure 4 shows the results obtained as 1n Figure 3 using beads linked to D99 via carbodlimide chemistry.

EXAMPLE 2 (Comparative) Experiments performed likewise with control pore glass coupling as described for the glass capillary of D99 via cyanogen bromide and carbodllmlde show almost identical results to those of Example 1 using those coupling reagents, i.e. as reported In Figures 3 and 4. - 19 EXAMPLE 3 This Example Illustrates the effect on hybridisation of Including an 8dT spacer arm in the Immobilised ollgo. Proceeding as 1n Example 1, with 0.2 pinole of ollgo D99 dlthlo-1 inked to 10 mg of the magnetic beads (a) with an 8dT spacer arm or (b) for comparison, without a nucleotide spacer arm, the results shown 1n Figure 5 were obtained. The filled circles represent results from the 8dT spaced Immobilised D99, while the filled squares are those for the unspaced Immobilised D99. Beads which were not coupled to the D99 gave counts of virtually zero. It 1s seen that the counts were somewhat higher from the nucleotide spacer arm-linked beads, Indicating Improved hybridisation.

EXAMPLE 4 This Example illustrates the effect on the hybridisation of Including a long (15 dT) spacer arm in the immobilised ollgo.

Following the procedure of Example 1, using 10 mg of the beads and, in one run, pre-washing the oligo-coupled beads for 5 minutes at 80pC Instead of at room temperature, and using a thiol-terminated oligo with a 15 dT instead of a 4 dT spacer, the data shown in the Table below were generated. There 1s a reduction in the amount of specific hybridisation compared with Example 1 in which the spacer was shorter. Possibly such a long spacer creates steric hindrance to hybridising ant1-D99.

TABLE Results of hybridisation of labelled ant1-D99 to 0.2 μΜ 15 dT D99 ollgo linked to 10 mg magnetic beads. Values represent counts released Into supernatant following Incubation 1n 2xSSC buffer at different temperatures shown In the left-hand column; at the bottom the counts from the beads are shown, I.e. analogously to the right-hand side of the Figures.

Wash Temp Control 15dT D99 15dT D99 °C (unactivated Beads) (room temp pre-wash) (80°C pre-wash) 40 103853 139028 183856 40 4100 11549 15336 40 1015 3769 1994 40 673 3982 1285 50 1371 7524 5018 60 2452 11495 9587 70 2056 24070 119099 80 4986 21539 10991 90 6152 29617 13471 90 + 2ME 4806 14904 11696 Beads 12499 73681 52337 2ME = 2-mercaptoethanol EXAMPLE 5 This Example illustrates immobilisation of DNA to a non-thiolated support (control pore glass) by constructing a dithio linkage. 0.25 g of 3000 Angstrom CPG, mesh size 60-120 Angstrom were reacted with 0.15ml (3-mercaptopropyl) trlmethoxysilane (Aldrich Chemical Co: technical grade 75%) in 3ml of acetone for 5 minutes at room temperature. The CPG was then washed 3 times with acetone, 3 times with diethyl ether and air dried. The yield in this experiment was 8 nanomoles/mg of available thiol groups, as assessed coupling cysteine to the mercaptopropyl-terminated CPG, cleaving the S-S bond, oxidising the cysteine and then amino acid analysis. Taking account of the reduced surface area of CPG compared with the magnetic beads, the yield 1s some 25-fold less than the thiol groups coupled in previous experiments. Thiolterminated D99 oligos with 4dT spacer (0.4 pmole) were then added to the CPG (1 mg.) in the way described in Example 1.

The D99 oligos coupled to the activated CPG were then hybridised to labelled anti-D99, as in previous Examples. For comparison, the same hybridisation was performed on 0.2pmoie of - 21 D99 coupled to Img of magnetic beads as 1n Example 1.

Since the CPG has 20 fold less thiol groups present on the surface, the hybridisation capacity of this DNA 1s considered as good as (1f not a little better) than that of the magnetic beads.

Counts in Supernatants Wash Temp °C Control (Unact!va Controlled Pore Glass Magnetic Beads Activated ted) No D99 present Activated coupled to D99 Activated No D99 present Activated coupled to D99 40 58256 80682 77450 (61051) 50056 40 4338 3878 4825 (3410) 3438 40 568 377 1084 (1433) 1588 40 160 150 645 (952) 1633 50 124 159 1421 (1669) 2419 60 225 238 5041 (3324) 10701 70 220 314 6205 (4877) 49296 80 394 384 5974 (7747) 102702 90 314 347 705 (4819) 21284 Beads 1134 1250 1358 17074 11282 EXAMPLE 6 This following Example demonstrates that double-stranded DNA simulating a PCR product, Immobilised onto magnetic particles (Biomag) via the dithlo-l1nkage described 1n Example 1, can be labelled by a 3' end-labelling reaction. 3 mg magnetic beads having ollgo D99 with a 4 dT spacer (0.2 μΜ per lOmg beads) coupled via the d1th1o-lInkage of the Invention were Incubated for 1 hour at 40eC with an excess of complementary ollgo (ant1-D99) either (1) as such or (2) with an additional 5'-poly dG sequence (of 6 dG bases) extending past the free 3' terminus of the Immobilised ollgo D99, (as shown below): ' 3' -S-S—TTTTTGAAAAGCCACTGTGTCCTG D99 AGTTTTCGGTGACACAGGACGGGGGG An 11-D99+6G 3' 5' The magnetic beads carrying this duplex of Immobilised - 22 double-stranded DNA were used as template In the 3' end-labelling reaction employing ^2p_jcTP as the labelling nucleotide, and Tag polymerase or Klenow fragment as the enzymes in Tag polymerase buffer. After labelling, whereby cytidine (dC) bases are added to complement the guanoslne (dG) tail, the reaction mixture was heated to 90°C, and whilst still at this temperature, the beads were removed by centrifugation. The beads were washed with 2xSSC at 90°C and the radioactivity (cpm) remaining on them was then determined by Cerenkov-counting. The results (Table 1) were compared to those obtained using D99-beads without enzyme present, or using magnetic beads alone (i.e. no immobilised D99).

The results demonstrate that substantial radioactive label (and therefore incorporation of 32P-dCTP t0 the 3' terminus of ollgo D99) Is present only using magnetic beads with dithio-1inked ollgo D99 in the presence of either Tag polymerase or Klenow fragment. Thus, the 3' terminus of the dithio-1inked oligo D99 on the magnetic beads is accessible to the DNA polymerase activity of both enzymes under the appropriate conditions. When Klenow fragment was used as the enzyme for the labelling reaction, the beads having the D99/ant1-D99 duplex without the dG tail showed a high background radioactive count. This can be ascribed to intrinsic exonuclease activity of Klenow fragment.

TABLE 1 Amount of radioactivity (cpm) on beads after being subjected to 3' end-labelling reaction using - 32P-dCTP Enzyme D99 Beads + anti-D99+6G D99 Beads + anti-D99 (control) Plain Beads (no D99) None 627 2004 774 Klenow 388359 94225 11093 Tag polymerase 1137481 8598 921 - 23 EXAMPLE 7 This Example demonstrates that DNA (oligo D99) d1thio-11nked to magnetic beads can function as the forward primer In the polymerase chain reaction for the amplification of target DNA (the E6 region of human papilloma virus type 16 (HPV16) genomic DNA), resulting In immobilisation of the PCR products as double stranded or (by heating the product to 90’C Immediately before separating solid from liquid phases) single stranded DNA. mg magnetic beads coupled to ollgo D99 (as in the previous example) were added to a total 100 μΐ PCR reaction mixture composed of recommended PCR buffer (Perkin-Elmer Cetus) in the presence of Caskl DNA (a cell line Infected with HPV16 genomic DNA) free (I.e. not immobilised) reverse primer (referred to as non-complementary primer 1n Example 1) or both free non-complementary primer and oligo D99. Reactants were preheated to 98°C for 7 minutes 5 units of Tag polymerase were added and a PCR was carried out for 40 temperature cycles composed of 96°C for 30 seconds (denaturatlon), 40°C for 30 seconds (annealing of primer to target) and 72°C for 1 minute (DNA synthesis by primer extension) performed on a Wolfson Programmable Thermal Cycler. Following cycling, supernatants were removed and the beads resuspended In 2xSSC heated to 90°C. The magnetic beads were removed by centrifugation and washed once with 2xSSC buffer at room temperature. This results 1n the dith1o-l1nked ollgo D99 and Its extension product remaining on the magnetic beads as single-stranded DNA. The beads were then probed with a 32P hexanucleotide-labelled 38mer ollgo complementary to a mid-sequence of the expected HPV16 PCR product (probe sequence = 5' AAAGATTCCATAATATAAGGGGCGGTGACCGGTCGATG 3’, Identified as Sequence ID No. 4). Hybridisation of pobe and assessment of hybridised probe were performed as described 1n Example 1, except that the amount of radioactivity remaining on the beads was determined. The results are given in Table 2 which also Includes the data obtained using magnetic beads alone (I.e. no dlthlo-Hnked ollgo D99) 1n the presence or absence of Tag polymerase and 1n reaction mixtures containing - 24 free (i.e. unlinked) reverse primer and forward primer.

TABLE 2 Results of hybridising 32P-1abe11ed mid-sequence probe to oligo D99 coupled magnetic beads after PCR cycling. Numbers refer to cpm after washes at different temperatures.

Bead Type Free Oligo Tag 40°C 50°C 60°C 70°C 80°C 90eC no D99 F + R + 13748 4948 5057 5080 7487 3783 + D99 R alone + 80287 77817 54634 19681 13724 9993 + D99 F + R + 66574 67716 61856 38463 34809 19369 no D99 F + R - 4123 3129 2873 3770 4399 3084 + D99 R alone - 23069 23908 18456 16807 17337 11923 + D99 F + R - 22437 20035 18977 15365 13694 12813 F refers to forward oligo primer (1.e. D99) and R refers to reverse primer. Tag = Tag polymerase.

The results demonstrate that using d1thio-11nked D99 magnetic particles, 1n the presence of free reverse primer (or both primers free) and Tag polymerase, specific amplification of the HPV16 E6 region is permissible.

The reaction scheme below shows a simplified version of a PCR carried out in the manner of Example 7, with a forward primer (D99) immobilised, a reverse primer 1n solution, and a single molecule of double-stranded HPV16 DNA.

If one amplification cycle is performed on dsDNA of HPV16 consisting of strands labelled B and C the results would be: (1) Extension of the immobilised forward primer to yield one new HPV16 strand of DNA immobilised to the solid phase, labelled A. (2) Extension of the reverse primer in solution to yield one new strand of HPV16 DNA which is opposite 1n sequence and orientation (i.e. complementary) to the strand generated in (1) above. This new strand is labelled D. (3) The two separate strands B and C, of the original HPV16 DNA. - 25 Upon cooling the reaction mixture to allow re-annealing of each of the separate strands A, B, C and D, the following Immobilised products would be obtained: (4) Immobilised dsDNA composed of the new strand A formed 05 by forward primer annealed to complementary strand B of HPV16 starting DNA template; or (5) Immobilised dsDNA composed of the new strand A formed by the forward primer annealed to the new complementary strand D generated by the reverse primer.

Both situations essentially result 1n one dsDNA immobilised and one in free solution. Further amplification in the presence of more of each primer, then (as 1n a regular PCR reaction) results In more dsDNA product (original template cannot Increase) which is immobilised to the solid phase. By heating to 90-100’C, the dsDNA 1s made single stranded which, using the above conditions, results in all the forward primer product being Immobilised and all the reverse primer product being in solution. - 26 FIRST CYCLE STAGE 1 : ANNEALING OF PRIMERS Immobilised forward primer ' 3' 3' HPV16 DNA template (strand 1) 5' B 5'- HPV16 DNA template (strand 2) 3' C 31 o-o—o—o—o—o—o—o 51 reverse primer in solution STAGE 2 : PRIMER EXTENSION, FOLLOWED BY SEPARATING THE STRANDS 5J________________________________________________3' A 3'- 5' B '- 3' c 3'---------------------------------------o—o—o—o—o—o—o—o 5' d 4RE-ANNEALING OF THE SINGLE STRAND PRODUCTS '____________________________ 3' A 3-- 5' β '- 3' C 3'---------------------------------------o-o-o-o-o-o-o-o 5' D I 5'________________________________________________3' A J 3'---------------------------------------o-o-o-o—o-o-o-o 5' D 3'- 5' B '- 3· c Of course, 1f the reverse primer were also to be Immobilised, then all the solid phase products would contain either the target HPV16 DNA (one strand or the other) or a copy of part of the target DNA made by the primer extension. - 27 S£QUEN£L±ISTING This sequence listing is provided 1n this International Patent Application to meet the requirements or wishes of certain contracting States (EPC countries, US, JP). The General Information Section is applicable only to US. (1) GENERAL INFORMATION: (1) Applicant : DAY, Philip J.R.

FOX, John E.

WALKER, Matthew R. (11) Title of Invention : Immobilised Polynucleotides (111) Number of Sequences : 4 (1v) Correspondence Address : Nixon & Vanderhye P.C., 14th Floor, 2200 Clarendon Boulevard, Arlington, Virginia, U.S.A. 22201 (v) Computer Readable Form: (a) Medium Type : Diskette, 5.25 inch, 360 Kb storage. (b) Computer : IBM PC/AT compatible. (c) Operating System: MS-DOS 3.2. (d) Software : Word Perfect ASCII File Format. (vi) Current Application Data: (a) Application Number : (b) Filing Date: (c) Classification: (vi1) Prior Application Data: (a) Application Number : PCT/GB 90/ (b) Filing Date (a) Application Number : GB 8915607.9 (b) Filing Date : 07 JUL 1989 (a) Application Number : GB 8921327.6 (b) Filing Date : 21 SEP 1989 (a) Application Number : GB 9008274.4 (b) Filing Date : 11 APR 1990 (vli 1) Attorney/Agent Information: (a) Name : Leonard C. Mitchard (b) Registration Number: 29,009 (c) Reference/Docket Number : (lx) Telecommunication Data (a) Telephone (b) Telefax (703) 875-0400 (703) 525-3468 (2) INFORMATION FOR SEQUENCE ID NO. 1 (1) Sequence Characteristics : (a) Length : 20 base pairs (b) Type : Nucleic acid (c) Strandedness : Double (d) Topology : Linear (xi) Sequence Description : Sequence ID No. 1 TCAAAAGCCA CTGTGTCCTG 20 (2) INFORMATION FOR SEQUENCE ID NO. 2 (1) Sequence Characteristics: (a) Length : 20 bases (b) Type : Nucleic acid (c) Strandedness : Single (d) Topology : Linear (x1) Sequence Description : Sequence ID No. 2 CAGGACACAC TGGCTTTTGA 20 (2) INFORMATION FOR SEQUENCE ID NO. 3 (1) Sequence Characteristics: (a) Length : 20 bases (b) Type : Nucleic acid (c) Strandedness : Single (d) Topology : Linear (xi) Sequence Description : Sequence ID No. 3 CGTGTTCTTG ATGATCTGCA 20 (2) INFORMATION FOR SEQUENCE ID NO. 4 (1) Sequence Characteristics (a) Length : 38 bases (b) Type : Nucleic acid (c) Strandedness : Single (d) Topology : Linear (x1> Sequence Description : Sequence ID No. 4 AAAGATTCCA TAATATAAGG GGCGGTGACC GGTCGATG

Claims (21)

1. An Immobilised polynucleotide material comprising a support bound to a 5'-end of at least one polynucleotide through a linkage which comprises a dlthlo (-S-S-) group.

2. An Immobilised polynucleotide material according to Claim 1 05 wherein the polynucleotide contains a c-target base sequence complementary to a base sequence of interest 1n a target polynucleotide, and wherein the c-target sequence 1s spaced from the support so as to permit the c-target sequence to hybridise to the target polynucleotide. 10

3. An immobilised polynucleotide material according to Claim 2 wherein the c-target sequence 1s spaced from the 5'-end of the polynucleotide by a spacer arm of one or more nucleotides which do not participate 1n or interfere with c-target/target hybridlsatlon. 15

4. An Immobilised polynucleotide material according to Claim 3 wherein the nucleotide spacer arm Is from 3 to 20 nucleotides long.

5. An Immobilised polynucleotide material according to Claim 4 wherein the nucleotide spacer arm is from 4 to 15 nucleotides 20 long.

6. An Immobilised polynucleotide material according to any preceding claim wherein the linkage includes a spacer arm between the support and the -S-S- group, between the -S-S- group and the 5'-end of the polynucleotide or both. 25 7. An Immobilised polynucleotide according to Claim 2 comprising a nucleotide spacer arm according to Claim 3, 4 or 5 and a linkage spacer arm according to Claim 6, which together conform to the general formula: (Ν) χ - (L i ) y -S-S- 2 ) Z 30 where:

N 1s a nucleotide attached to the 5'-end of the c-target sequence and where there Is more than one such nucleotide they may be the same or different; - 30 I_1 and L 2 are atoms in a chain from the 5'-end nucleotide of the polynucleotide to the support, on each side of the two S atoms of the -S-S-linkage; x, y and z are 0 or Integers and the sum of x, y and z is 3 05 to 25.

8. A method of producing an immobilised polynucleotide material according to Claim 1, which comprises reacting a 5'-(thio1-terminated) derivative of at least one polynucleotide with a support having a thiol group thereon, either or both of 10 said thiol groups being -SH groups as such or derivatised as co-reactive -S-S- linkage-producing derivatives, to form a said -S-S- linkage between said thiol groups.

9. A method according to Claim 8, wherein the polynucleotide contains a c-target base sequence complementary to a target 15 sequence of interest in another polynucleotide and wherein spacing is provided within the thiol-terminated polynucleotide between the target sequence and the thiol termination, within the thiolated support between the support and the thiol group or within both, said spacing being in total, after reaction to form 20 the -S-S- linkage, effective to space the support from the c-target sequence to permit the c-target sequence to hybridise to the target sequence.

10. A method according to Claim 9 wherein spacing 1s provided as defined in Claim 4, 5 or 7. 25

11. A method of carrying out a polymerase chain reaction (PCR) in which an Immobilised polynucleotide material claimed in any one of Claims 1 - 7 or prepared by a method claimed in any one of Claims 8 - 10 is substituted for either or both of the oligonucleotide primers used in the PCR and the amplified product 30 of the PCR is separated on the solid phase.

12. A method of carrying out a PCR reaction which comprises: (1) annealing forward and reverse oligonucleotide primers, which are immobilised polynucleotide materials as defined in Claim 11, to the strands of a polynucleotide to be amplified which serve as - 31 templates, the annealing being carried out at a temperature of 30 to 60°C. 2. (2) extending the primed sequences along their respective template strands of the polynucleotide to be amplified, at a 05 temperature of from 60 to 80°C, <3> separating the thus synthesised strands from their templates at a temperature of 80 to 100°C and repeating the process by using the separated strands as templates.

13. A method according to Claim 11 or 12 wherein the amplified 10 products of the PCR are labelled and the PCR 1s used to assay a sequence of the polynucleotide to be amplified.

14. A method of heterogeneous assay for an analyte nucleic acid, which comprises subjecting an Immobilised polynucleotide material according to any one of Claims 1 - 7 or prepared by a method

15 claimed in any one of Claims 8 - 10, having a c-target base sequence complementary to a target sequence of analyte nucleic acid present In a liquid phase analyte, hybridising the c-target sequence to the target sequence separating the phases and determining the occurrence or extent of hybridisation. 20 15. A method according to Claim 14 wherein the analyte nucleic acid 1s generated by a liquid phase PCR.

16. An immobilised polynucleotide material substantially as described herein with reference to the accompanying drawings and/or the Examples.

17. A method of producing an immobilised polynucleotide material substantially as described herein with reference to the accompanying drawings and/or the Examples.

18. An immobilised polynucleotide material whenever produced by a method as claimed in any of Claims 8 to 10 or 17.

19. A method of carrying out a PCR substantially as described herein with reference to the accompanying drawings and/or the Examples - 31a

20. A method of heterogeneous assay for an analyte nucleic acid substantially as described herein with reference to the accompanying drawings and/or the Examples.

21. A test kit comprising an immobilised polynucleotide material as claimed in any of Claims 1 to 7, 16 or 18. DATED THIS 6th day of July, 1990 BY: T(3|MKINS & CO.